Boston, MANCT06852768Now EnrollingIRB Ready

Graft-Versus-Host Disease Clinical Trial in Boston, MA

Access cutting-edge graft-versus-host disease treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Regenerative Ocular Immunobiologics LLC

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions...

Expert Care in Boston

Access graft-versus-host disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related graft-versus-host disease treatment provided free

Apply for This Boston Location

Check if you qualify for this graft-versus-host disease clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Graft-Versus-Host Disease Study in Boston

A Double-Masked, Randomized, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of d-MAPPS™ Ophthalmic Solution in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGHVD)

Sponsor: Regenerative Ocular Immunobiologics LLC

Who Can Participate

Inclusion Criteria

Age ≥ 18 years.
Willing and able to provide written informed consent.
Willing and able to comply with study assessments for the full duration of the study.
Patients may be using bilateral scleral lenses and/or bilateral punctal plugs at the time of accrual.
Minimum Oxford Schema grad of ≥ 1 in at least one eye.
OSDI scored of ≥ 22.
UNC DEMS score of ≥ 3.
In good stable overall health.

Exclusion Criteria

History of Rheumatoid Arthritis, Lupus, Scleroderma.
Ocular or periocular malignancy.
Significant change, as judged by the principal investigator, in systemic immunosuppressive regimen within 2 weeks of study entry.
Any history of topical tacrolimus use.
Any change in dosage of tetracycline compounds (tetracycline, doxycycline, and minocycline) within the last month.
Any change in frequency of preserved anti-glaucoma medications within 2 weeks of study entry.
Current use of topical steroids more than twice a day.
Corneal epithelial

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06852768) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Graft-Versus-Host Disease Treatment Options in Boston, MA

If you're searching for graft-versus-host disease treatment options in Boston, MA, this clinical trial (NCT06852768) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced graft-versus-host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all graft-versus-host disease clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Boston, MA

See all atrial fibrillation clinical trials recruiting in Boston — not just this study.

Browse Atrial Fibrillation Trials in Boston →

Browse More Trials by Condition

Atrial Fibrillation TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA